Published in J Mol Model on October 21, 2005
Recent advances in ligand-based drug design: relevance and utility of the conformationally sampled pharmacophore approach. Curr Comput Aided Drug Des (2011) 0.97
In silico prediction of estrogen receptor subtype binding affinity and selectivity using statistical methods and molecular docking with 2-arylnaphthalenes and 2-arylquinolines. Int J Mol Sci (2010) 0.84
Quantitative structure-activity relationship study of P2X7 receptor inhibitors using combination of principal component analysis and artificial intelligence methods. Res Pharm Sci (2015) 0.78
QSAR models for predicting the activity of non-peptide luteinizing hormone-releasing hormone (LHRH) antagonists derived from erythromycin A using quantum chemical properties. J Mol Model (2007) 0.75
Practice guidelines for the treatment of candidiasis. Infectious Diseases Society of America. Clin Infect Dis (2000) 5.73
Predictive QSAR modeling based on diversity sampling of experimental datasets for the training and test set selection. J Comput Aided Mol Des (2002) 1.77
Antifungals: mechanism of action and resistance, established and novel drugs. Curr Opin Microbiol (1998) 1.63
Synthesis of some new 2-substituted-phenyl-1H-benzimidazole-5-carbonitriles and their potent activity against Candida species. Bioorg Med Chem (2002) 1.37
Evolutionary optimization in quantitative structure-activity relationship: an application of genetic neural networks. J Med Chem (1996) 1.25
Synthesis and structure-activity relationships of new antimicrobial active multisubstituted benzazole derivatives. Eur J Med Chem (2004) 1.10
Structure/response correlations and similarity/diversity analysis by GETAWAY descriptors. 1. Theory of the novel 3D molecular descriptors. J Chem Inf Comput Sci (2002) 1.02
Antifungal agents. 10. New derivatives of 1-[(aryl)[4-aryl-1H-pyrrol-3-yl]methyl]-1H-imidazole, synthesis, anti-candida activity, and quantitative structure-analysis relationship studies. J Med Chem (2002) 0.96
Selective inhibitors of Candida albicans dihydrofolate reductase: activity and selectivity of 5-(arylthio)-2,4-diaminoquinazolines. J Med Chem (1995) 0.93
Membrane transporters and antifungal drug resistance. Curr Drug Targets (2000) 0.92
Antibacterial and antifungal activities of benzimidazole and benzoxazole derivatives. Antimicrob Agents Chemother (1981) 0.91
Structure-cytotoxicity relationships for a series of HEPT derivatives. J Mol Model (2002) 0.87
Quantitative structure-activity relationship to predict differential inhibition of aldose reductase by flavonoid compounds. Bioorg Med Chem (2005) 0.86
Toward an optimal procedure for PC-ANN model building: prediction of the carcinogenic activity of a large set of drugs. J Chem Inf Model (2005) 0.85
Enhancement of binary QSAR analysis by a GA-based variable selection method. J Mol Graph Model (2002) 0.80
Neural networks studies: quantitative structure-activity relationships of antifungal 1. Chemosphere (2001) 0.79
A quantitative structure--activity relationships model for the acute toxicity of substituted benzenes to Tetrahymena pyriformis using Bayesian-regularized neural networks. Chem Res Toxicol (2000) 0.78
QSARs of some novel isosteric heterocyclics with antifungal activity. Acta Biochim Pol (2000) 0.78
TOPS-MODE versus DRAGON descriptors to predict permeability coefficients through low-density polyethylene. J Comput Aided Mol Des (2003) 0.77
Proteometric study of ghrelin receptor function variations upon mutations using amino acid sequence autocorrelation vectors and genetic algorithm-based least square support vector machines. J Mol Graph Model (2006) 0.83
QSAR for non-nucleoside inhibitors of HIV-1 reverse transcriptase. Bioorg Med Chem (2006) 0.82
Modeling of farnesyltransferase inhibition by some thiol and non-thiol peptidomimetic inhibitors using genetic neural networks and RDF approaches. Bioorg Med Chem (2005) 0.81
Amino acid sequence autocorrelation vectors and Bayesian-regularized genetic neural networks for modeling protein conformational stability: gene V protein mutants. Proteins (2007) 0.81
Quantitative structure-activity relationship of rubiscolin analogues as delta opioid peptides using comparative molecular field analysis (CoMFA) and comparative molecular similarity indices analysis (CoMSIA). J Agric Food Chem (2007) 0.81
Amino Acid Sequence Autocorrelation vectors and ensembles of Bayesian-Regularized Genetic Neural Networks for prediction of conformational stability of human lysozyme mutants. J Chem Inf Model (2006) 0.80
Genetic neural network modeling of the selective inhibition of the intermediate-conductance Ca2+ -activated K+ channel by some triarylmethanes using topological charge indexes descriptors. J Comput Aided Mol Des (2005) 0.78
Structural requirements of pyrido[2,3-d]pyrimidin-7-one as CDK4/D inhibitors: 2D autocorrelation, CoMFA and CoMSIA analyses. Bioorg Med Chem (2008) 0.78
Quantitative structure-activity relationship of organosulphur compounds as soybean 15-lipoxygenase inhibitors using CoMFA and CoMSIA. Chem Biol Drug Des (2010) 0.78
2D Autocorrelation modeling of the negative inotropic activity of calcium entry blockers using Bayesian-regularized genetic neural networks. Bioorg Med Chem (2006) 0.78
QSAR analysis for heterocyclic antifungals. Bioorg Med Chem (2007) 0.78
A CoMSIA study on the adenosine kinase inhibition of pyrrolo[2,3-d]pyrimidine nucleoside analogues. Bioorg Med Chem (2008) 0.76
Artificial neural networks from MATLAB in medicinal chemistry. Bayesian-regularized genetic neural networks (BRGNN): application to the prediction of the antagonistic activity against human platelet thrombin receptor (PAR-1). Curr Top Med Chem (2008) 0.76
Docking and quantitative structure-activity relationship studies for sulfonyl hydrazides as inhibitors of cytosolic human branched-chain amino acid aminotransferase. Mol Divers (2009) 0.76
Identification of a potent and selective σ₁ receptor agonist potentiating NGF-induced neurite outgrowth in PC12 cells. Bioorg Med Chem (2011) 0.76
Quantitative structure-activity relationship modeling of growth hormone secretagogues agonist activity of some tetrahydroisoquinoline 1-carboxamides. Chem Biol Drug Des (2007) 0.75
Functional stabilization of trypsin by conjugation with beta-cyclodextrin-modified carboxymethylcellulose. Prep Biochem Biotechnol (2003) 0.75
2D autocorrelation modelling of the inhibitory activity of cytokinin-derived cyclin-dependent kinase inhibitors. Bull Math Biol (2006) 0.75
Transglutaminase-catalyzed synthesis of trypsin-cyclodextrin conjugates: kinetics and stability properties. Biotechnol Bioeng (2003) 0.75
2D Autocorrelation, CoMFA, and CoMSIA modeling of protein tyrosine kinases' inhibition by substituted pyrido[2,3-d]pyrimidine derivatives. Bioorg Med Chem (2007) 0.75
Thermal stabilization of trypsin by enzymic modification with beta-cyclodextrin derivatives. Biotechnol Appl Biochem (2003) 0.75